http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211817-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104211817-B |
| titleOfInvention | A kind of hydrophobin inactivation protein vaccine, its preparation method and application |
| abstract | The present invention provides a kind of new recombinant rabies virus albumen, and the recombinant protein is that hydrophobin envelope protein and hydrophobin stromatin autonomous assembling by having merged bionical core peptide are formed；The hydrophobin envelope protein for having merged bionical core peptide refers to that bionical core peptide is incorporated into the recombinant protein that hydrophobin membrane glycoprotein C-terminal is formed by Reverse Genetics.The present invention also provides the method that the recombinant protein is produced using baculoviral/insect cell expression system.After recombinant rabies virus albumen inactivation prepared by the baculoviral/insect cell expression system, mix with preservative, that is, prepare hydrophobin inactivation protein vaccine.The present invention prepare vaccine have the advantages that immunogenicity it is good, heat-resist, safe, without adjuvant. |
| priorityDate | 2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 244.